IQVIA Holdings Inc. (IQV)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS46266C1053
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by IQVIA Holdings Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:42. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 3.58 | — | — | Upcoming |
| 27 Oct 2026 07:00 | 3.28 | 3.34 | +2.0% | Beat |
| 28 Jul 2026 07:00 | 3.03 | 3.15 | +3.9% | Beat |
| 05 May 2026 07:00 | 2.82 | 2.90 | +3.0% | Beat |
| 05 Feb 2026 07:00 | 3.40 | 3.42 | +0.7% | In line |
| 28 Oct 2025 07:00 | 2.98 | 3.00 | +0.8% | In line |
| 22 Jul 2025 07:00 | 2.77 | 2.81 | +1.4% | Beat |
| 06 May 2025 07:00 | 2.63 | 2.70 | +2.6% | Beat |
| 06 Feb 2025 07:00 | 3.11 | 3.12 | +0.4% | In line |
| 31 Oct 2024 07:00 | 2.81 | 2.84 | +1.0% | Beat |
| 22 Jul 2024 07:00 | 2.56 | 2.64 | +3.0% | Beat |
| 02 May 2024 07:00 | 2.48 | 2.54 | +2.4% | Beat |
| 14 Feb 2024 07:00 | 2.82 | 2.84 | +0.7% | In line |
| 01 Nov 2023 16:00 | 2.45 | 2.49 | +1.8% | Beat |
| 01 Aug 2023 07:00 | 2.37 | 2.43 | +2.5% | Beat |
| 27 Apr 2023 07:00 | 2.41 | 2.45 | +1.7% | Beat |
| 10 Feb 2023 07:00 | 2.76 | 2.78 | +0.6% | In line |
| 26 Oct 2022 07:00 | 2.38 | 2.48 | +4.0% | Beat |
| 21 Jul 2022 07:00 | 2.38 | 2.44 | +2.4% | Beat |
| 27 Apr 2022 07:00 | 2.42 | 2.47 | +2.2% | Beat |
| 15 Feb 2022 07:00 | 2.43 | 2.55 | +4.8% | Beat |
| 21 Oct 2021 07:00 | 2.12 | 2.17 | +2.2% | Beat |
| 27 Jul 2021 07:00 | 2.08 | 2.13 | +2.5% | Beat |
| 22 Apr 2021 07:00 | 1.86 | 2.18 | +17.5% | Beat |
| 10 Feb 2021 07:00 | 2.01 | 2.11 | +5.2% | Beat |
| 20 Oct 2020 07:00 | 1.54 | 1.63 | +5.9% | Beat |
| 22 Jul 2020 07:00 | 1.06 | 1.18 | +11.7% | Beat |
| 28 Apr 2020 08:00 | 1.49 | 1.50 | +0.8% | In line |
| 12 Feb 2020 07:00 | 1.72 | 1.74 | +1.1% | Beat |
| 30 Oct 2019 07:00 | 1.57 | 1.60 | +1.7% | Beat |
| 24 Jul 2019 07:00 | 1.49 | 1.53 | +2.5% | Beat |
| 01 May 2019 07:00 | 1.51 | 1.53 | +1.5% | Beat |
| 14 Feb 2019 07:00 | 1.47 | 1.50 | +2.0% | Beat |
| 22 Oct 2018 07:00 | 1.39 | 1.42 | +2.2% | Beat |
| 24 Jul 2018 07:00 | 1.23 | 1.29 | +4.6% | Beat |
| 02 May 2018 07:00 | 1.27 | 1.34 | +5.2% | Beat |
| 14 Feb 2018 07:00 | 1.34 | 1.40 | +4.1% | Beat |
| 26 Oct 2017 07:00 | 1.14 | 1.19 | +4.7% | Beat |
| 03 Aug 2017 07:00 | 1.05 | 1.09 | +3.8% | Beat |
| 03 May 2017 07:00 | 0.96 | 1.01 | +5.4% | Beat |
| 14 Feb 2017 07:00 | 1.05 | 0.46 | -56.7% | Miss |
| 02 Nov 2016 07:00 | 0.98 | 1.00 | +1.8% | Beat |
| 27 Jul 2016 06:00 | 0.90 | 0.93 | +3.3% | Beat |
| 03 May 2016 06:00 | 0.86 | 0.89 | +3.2% | Beat |
| 11 Feb 2016 06:00 | 0.87 | 0.90 | +3.8% | Beat |
| 28 Oct 2015 06:00 | 0.81 | 0.94 | +15.5% | Beat |
| 29 Jul 2015 06:00 | 0.70 | 0.78 | +12.1% | Beat |
| 29 Apr 2015 06:00 | 0.71 | 0.72 | +1.6% | Beat |
| 12 Feb 2015 06:00 | 0.67 | 0.71 | +5.4% | Beat |
| 30 Oct 2014 06:00 | 0.64 | 0.65 | +1.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 16.3B | +5.9% | 1.4B | 8.3% | 7.84 | +4.7% | 2.1B |
| 2024 | 15.4B | +2.8% | 1.4B | 8.9% | 7.49 | +2.7% | 2.1B |
| 2023 | 15B | +4.0% | 1.4B | 9.1% | 7.29 | +27.4% | 1.5B |
| 2022 | 14.4B | — | 1.1B | 7.6% | 5.72 | — | 1.6B |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 277.44 | 277.44 | 266.23 | 271.11 | -1.25% | 1,041,100 | |
| 11 Nov 2026 | 276.89 | 281.24 | 274.32 | 274.53 | -0.23% | 1,365,400 | |
| 10 Nov 2026 | 278.04 | 278.04 | 274.10 | 275.15 | -1.32% | 1,001,600 | |
| 09 Nov 2026 | 274.00 | 279.96 | 270.00 | 278.84 | +2.58% | 1,466,800 | |
| 06 Nov 2026 | 264.21 | 273.46 | 261.20 | 271.83 | +2.62% | 1,398,400 | |
| 05 Nov 2026 | 267.28 | 267.28 | 261.00 | 264.88 | +0.41% | 1,738,200 | |
| 04 Nov 2026 | 263.04 | 269.28 | 260.44 | 263.79 | +0.46% | 1,379,500 | |
| 03 Nov 2026 | 255.65 | 263.99 | 252.38 | 262.59 | +1.61% | 1,321,600 | |
| 02 Nov 2026 | 269.43 | 270.00 | 257.35 | 258.44 | -3.33% | 1,368,100 | |
| 30 Oct 2026 | 274.91 | 274.91 | 263.21 | 267.33 | -2.81% | 1,150,200 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- IQVIA: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 10 Nov 2026 01:52
- IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised (opens in a new tab) StockStory · 30 Oct 2026 21:31
- 5 revealing analyst questions from IQVIA’s Q3 earnings call (opens in a new tab) StockStory · 30 Oct 2026 21:15
- IQVIA (IQV) Q3 Earnings Beat Meets Valuation And Debt Questions (opens in a new tab) Simply Wall St. · 28 Oct 2026 08:09
- What IQVIA (IQV) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 27 Oct 2026 20:04
- IQVIA (IQV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 27 Oct 2026 18:14
- IQVIA Holdings Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 27 Oct 2026 17:50
- IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y (opens in a new tab) Zacks · 27 Oct 2026 13:42
- IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue (opens in a new tab) StockStory · 27 Oct 2026 11:58
- IQVIA: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 27 Oct 2026 11:15
- IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 27 Oct 2026 11:15
- IQVIA (IQV) Q3 earnings report preview: what to look for (opens in a new tab) StockStory · 26 Oct 2026 10:06
- Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat (opens in a new tab) Insider Monkey · 23 Oct 2026 17:20
- From Headwinds to Full Valuation: The Disciplined Exit of IQVIA Holdings (IQV) (opens in a new tab) Insider Monkey · 23 Oct 2026 16:44
- IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know (opens in a new tab) Zacks · 22 Oct 2026 13:58
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 274.53 USD
- Market cap
- 44.7B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow IQV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.